Compare Essex Property Trust, Inc. (ESS) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Essex Property Trust, Inc. vs TransMedics Group Inc — how do they compare? Essex Property Trust, Inc. trades at $273.46 (market cap $17.26B), while TransMedics Group Inc trades at $77.62 (market cap $2.74B). The key difference: Essex Property Trust, Inc. is far larger — about 6.3× TransMedics Group Inc's market cap, and Essex Property Trust, Inc. pays a 3.86% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Essex Property Trust, Inc. for 111 Days and TransMedics Group Inc for 24 Days on average.
| ESS | TMDX | |
|---|---|---|
Market Cap | $17.26B | $2.74B |
Volume | 454,464 | 949,331 |
Sector | Real Estate | Health |
52-Week High | $298.33 | $150.42 |
52-Week Low | $239.61 | $61.99 |
Typical Hold Time | 111 Days | 24 Days |
Enterprise Value | $23.86B | $3.13B |
Dividend Yield | 3.86% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ESS trades at $270.20, up 0.8% with mixed technical signals showing bearish moving averages but neutral oscillators. The company reported strong Q2 2026 results beating FFO guidance and raised full-year outlook, though recent earnings show volatility with two misses in the last four quarters. Revenue has grown steadily from $1.6B in 2022 to $1.9B in 2025, while profit margins remain healthy at 35.48%.
The stock presents a compelling opportunity with 18 buy ratings and consensus price target of $303.41 (12.3% upside), supported by strong operational performance and litigation resolution. Key risks include elevated valuation multiples (P/E 41.83) and debt levels, while institutional buying from BlackRock and Canada Pension Plan provides confidence in the recovery thesis.
TransMedics Group (TMDX) trades at $80.69, down 0.47% on the day, amid a bearish technical signal and mixed earnings performance. The company reported strong revenue growth to $605.49M in 2025 with a net income margin of 22.69%, but recent quarters have seen earnings misses. Analyst sentiment remains positive with a consensus price target of $99.75 and a 69% buy rating, though news flow includes investigations into fiduciary duties.
The outlook balances robust fundamentals against near-term headwinds. Upside potential exists from the high analyst target and strong profitability metrics like a 36.28% ROE, but risks include earnings volatility, margin pressure, and ongoing legal scrutiny. The stock's current valuation at a P/E of 20.47 offers a reasonable entry if execution improves.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Essex Property Trust, Inc.
Essex Property Trust owns a portfolio of 253 apartment communities with over 62,000 units and is developing three additional properties with 571 units. The company focuses on owning large, high-quality properties on the West Coast in the urban and suburban submarkets of Southern California, Northern California, and Seattle.
Read more on ESS →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
